Volume 17, Issue 3 (7-2025)
jorar 2025, 17(3): 168-173 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Valizadeh T, Soltani H, Rousta A, Ashrafi A. The Impact of Factors Affecting Policy-Making in the Field of Drug Supply, Production, and Distribution in the Iranian Red Crescent Society. jorar 2025; 17 (3) :168-173
URL: http://jorar.ir/article-1-1033-en.html
URL: http://jorar.ir/article-1-1033-en.html
Department of Management, Shi.C., Islamic Azad University, Shiraz, Iran
Abstract: (179 Views)
INTRODUCTION: Since proper planning for the supply, production, and distribution of medicines, especially in emergencies and humanitarian crises, relies on efficient and responsive management. Therefore, the present study aimed to investigate the factors affecting the policy-making of the supply, production, and distribution of medicines in the RCS.
METHODS: In this descriptive-analytical study, all decision-makers, planners, and specialists of the RCS in the field of supply, production, and distribution of medicines were studied, and 365 people were selected and examined using a simple random sampling method and the Cochran formula. Data were collected using a researcher-made questionnaire whose validity and reliability were confirmed by experts and Cronbach's alpha (α=0.92). Data analysis was performed using the structural equation modeling (SEM) method in SmartPLS software.
FINDINGS: Based on the findings, issues such as security and stability in drug supply, creating responsive and flexible structures in distribution, strategic planning and raw material supply chain management, facilitating and improving distribution and logistics processes, ensuring quality and standardizing production, fair and equitable distribution of drugs, developing purchasing infrastructure and new technologies, developing domestic capacities and self-sufficiency in production, continuous monitoring of the distribution process, effective monitoring and evaluation system, extensive coordination and cooperation with stakeholders, strategic and international cooperation, flexibility and accountability in production policies, flexibility in the purchasing process, and continuing research, development, and innovation in production, all have a positive and significant relationship with drug supply, production, and distribution policymaking in the IRCS. Also, all research hypotheses were confirmed (p<0.05).
CONCLUSION: The results show that to improve processes, policymakers should pay special attention to infrastructure development, strategic partnerships, flexibility in policymaking, and strengthening domestic capacities.
METHODS: In this descriptive-analytical study, all decision-makers, planners, and specialists of the RCS in the field of supply, production, and distribution of medicines were studied, and 365 people were selected and examined using a simple random sampling method and the Cochran formula. Data were collected using a researcher-made questionnaire whose validity and reliability were confirmed by experts and Cronbach's alpha (α=0.92). Data analysis was performed using the structural equation modeling (SEM) method in SmartPLS software.
FINDINGS: Based on the findings, issues such as security and stability in drug supply, creating responsive and flexible structures in distribution, strategic planning and raw material supply chain management, facilitating and improving distribution and logistics processes, ensuring quality and standardizing production, fair and equitable distribution of drugs, developing purchasing infrastructure and new technologies, developing domestic capacities and self-sufficiency in production, continuous monitoring of the distribution process, effective monitoring and evaluation system, extensive coordination and cooperation with stakeholders, strategic and international cooperation, flexibility and accountability in production policies, flexibility in the purchasing process, and continuing research, development, and innovation in production, all have a positive and significant relationship with drug supply, production, and distribution policymaking in the IRCS. Also, all research hypotheses were confirmed (p<0.05).
CONCLUSION: The results show that to improve processes, policymakers should pay special attention to infrastructure development, strategic partnerships, flexibility in policymaking, and strengthening domestic capacities.
Article Type: Research article |
Subject:
Healthcare and rehabilitation in disasters
References
1. Keikha A, Shahreki Z, Haddadi E, Nouri Delavar M. [The role of Red Crescent Society public education in urban crisis management (Persian)]. Journal of Rescue & Relief, 2018; 10 (2) :1-17
2. Moghimi S.M., Vakili F., Manovarian A. [Designing an entrepreneurial policy-making model for sustainable financing of the Iranian health system (case study: Kurdistan province health system) (Persian)]. Journal of Entrepreneurship Development. 2024; 17(2):56-84. [DOI:10.22059/jed.2024.374509.654349]
3. Allaf Jafari E., Rousta A., Asayesh F., Ahmadi-Sharif M. [A revolution in insurance marketing innovation: sustainable marketing with an artificial intelligence approach (Persian)]. Journal of Innovation and Creativity in Human Science, 2024; 14(2): 57-79.
4. Hosseini R, Nazifi R. [Investigation and explanation of the optimal model of management system policy-making in organizational decision-making of the Red Crescent Society(Persian)]. Management of Government Organizations, 2024;12 (45): 89-108. [DOI:10.30473/ipom.2023.67383.4805]
5. Ebrahimi SA, Farhadinejad M, Baki Hashemi SM. [Analysis of policy making in the health system based on the advocacy coalition framework model (case study: health system transformation plan) (Persian)]. Strategic Studies Quarterly. 2020; 23(2): 95-112.
6. Kazemi S., Kolivand P., Saberian P., [phenomenological analysis of factors that affect the increase in the willingness to reengage volunteer rescuers and saviors of the IRCS (Persian)]. Disaster Medicine and Public Health Preparedness, 2024; 18, e237. [DOI:10.1017/dmp.2024.179]
7. Kline, R. B. Principles and practice of structural equation modeling. Guilford Press publication. Fifth edition, 2023
8. Khajeh M., Raei M, Ansari Mahyari A. [Obligation to international cooperation in the event of disasters (Persian)]. Journal of Legal Research, 2023; 22(55): 49-80. [DOI:10.48300/jlr.2022.345764.2077]
9. Bahrami F, Zarei A, Shafiei Nikabadi M, Farrokhizadeh F. [Investigating the performance of the drug supply and distribution chain using blockchain technology based on the dynamic system approach (Persian)]. Journal of Modern Research in Decision Making, 2024; 9(3):34-70.
10. Ciceri, C., Borsani, C., Guida, M., Farinelli, M., Caniato, F. Impact pathways: navigating risks in the pharmaceutical supply chain-a multi-actor perspective. International Journal of Operations Production Management, 2025; 45 (13): 53-62 [DOI:10.1108/IJOPM-06-2024-0458]
11. Tucker E.L., Daskin M.S. Pharmaceutical supply chain reliability and effects on drug shortages. Journal of Computers Industrial Engineering, 2022; 169:108258. [DOI:10.1016/j.cie.2022.108258]
12. Methuku V. Optimizing drug distribution using reinforcement learning in pharmaceutical logistics. International Journal of Pharmaceutical Supply Chain Management, 2025; 16 (1): 22-38. [DOI:10.20944/preprints202503.0638.v1]
13. Ogbuagu O. O., Mbata, A. O et al. Optimizing supply chain logistics for personalized medicine: Strengthening drug discovery, production, and distribution. International Journal of Multidisciplinary Research and Growth Evaluation, 2023; 4 (1): 832-841. [DOI:10.54660/.IJMRGE.2023.4.1-832-841]
14. Azar A, Khorrami A. [Designing a supply chain agility model in the pharmaceutical industry with an interpretive structural modeling (ISM) approach (Persian)]. Journal of Public Management Research, 2021; 14(53): 29-63. [DOI:10.22111/jmr.2021.34316.5081]
15. Dieleman J.L., Sadat, N., Chang A.Y., Fullman N., Abbafati C., et al. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40. The Lancet, 2018;391(10132):1783-1798. [DOI:10.1016/S0140-6736(18)30697-4]
16. Chiumia FK, Chithope-Mwale C, Abikoloni F, Matchaya V, Gaviyawo T, Khuluza F. Availability, pricing, and affordability of essential medicines for pediatric population in Malawi. Front Pharmacol. 2024;11(15):1379250. [DOI:10.3389/fphar.2024.1379250]
17. Kangarlou Haghighi R, Toloui Ashlaghi A, Motadel M. [Agent-based modeling of an online drug distribution monitoring system with a reinforcement learning approach(Persian)]. Journal of Industrial Management Perspectives, 2024; 13(3): 249-284. [DOI:10.48308/jimp.13.3.249]
18. Godman, B., Fadare, J., Kwon, H.-Y., Dias, C. Z., et al. Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research, 2021;10 (12): 1019-1052. [DOI:10.2217/cer-2020-0273]
19. Boström, E. Are we keeping everyone safe from disasters? A qualitative case study on how the IFRC promotes an intersectional understanding of gender within disaster risk reduction projects for resilience. Global Environmental Change, 2021 Available from: https://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=9052659&fileOId=9052663
20. Hussain, F., Tsang, D., Rafique, Policy advisory systems and public policy making: bibliometric analysis, knowledge mapping, operationalization, and future research agenda. Journal of Review of Policy Research, 2024; 41 (5): 713-739. [DOI:10.1111/ropr.12564]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
